Literature DB >> 11586209

Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate.

A C Spetz1, B Pettersson, E Varenhorst, E Theodorsson, L H Thorell, M Hammar.   

Abstract

PURPOSE: In women the vasodilatory neuropeptides calcitonin gene-related peptide and neuropeptide Y seem to be involved in menopausal hot flashes. We assessed whether plasma calcitonin gene-related peptide and neuropeptide Y change during hot flashes in men after castration.
MATERIALS AND METHODS: We evaluated 10 men 61 to 81 years old who underwent castration due to cancer of the prostate and had frequent hot flashes for changes in plasma calcitonin gene-related peptide and neuropeptide Y during 1 day at the outpatient clinic. At least 5 blood samples were obtained between flashes and 4 were obtained during each flash. The samples were analyzed for calcitonin gene-related peptide and neuropeptide Y using radioimmunoassay technique. Hot flashes were objectively recorded by measuring peripheral skin temperature and skin conductance.
RESULTS: Plasma calcitonin gene-related peptide increased 46% (95% confidence interval 21 to 71) during flashes in the 6 men in whom it was measurable. This change was statistically significant (p = 0.028). The concentration of neuropeptide Y was below the detection limit. Skin conductance and temperature increased significantly during flashes.
CONCLUSIONS: Calcitonin gene-related peptide is involved in the mechanisms of hot flashes in men who underwent castration due to prostate carcinoma. Thus, there may be a similar mechanism of hot flashes in women and in men deprived of sex steroids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586209

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Acupuncture for hot flashes in patients with prostate cancer.

Authors:  Tomasz M Beer; Maria Benavides; Sandra L Emmons; Margaret Hayes; Guohui Liu; Mark Garzotto; Deirdre Donovan; Nina Katovic; Caron Reeder; Kristine Eilers
Journal:  Urology       Date:  2010-05-21       Impact factor: 2.649

Review 2.  Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Authors:  William I Fisher; Aimee K Johnson; Gary R Elkins; Julie L Otte; Debra S Burns; Menggang Yu; Janet S Carpenter
Journal:  CA Cancer J Clin       Date:  2013-01-25       Impact factor: 508.702

Review 3.  Role of calcitonin gene-related peptide in energy metabolism.

Authors:  William Gustavo Lima; Gleuber Henrique Marques-Oliveira; Thaís Marques da Silva; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2017-09-07       Impact factor: 3.633

Review 4.  Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?

Authors:  Maria Alice Oliveira; William Gustavo Lima; Dante Alighieri Schettini; Cristiane Queixa Tilelli; Valéria Ernestânia Chaves
Journal:  Endocrine       Date:  2018-10-10       Impact factor: 3.633

5.  Acupuncture as treatment of hot flashes and the possible role of calcitonin gene-related Peptide.

Authors:  Anna-Clara E Spetz Holm; Jessica Frisk; Mats L Hammar
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-26       Impact factor: 2.629

Review 6.  Anti-inflammatory actions of acupuncture.

Authors:  Freek J Zijlstra; Ineke van den Berg-de Lange; Frank J P M Huygen; Jan Klein
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

7.  Efficacy and safety of keishibukuryogan, a traditional Japanese Kampo medicine, for hot flashes in prostate cancer patients receiving androgen deprivation therapy.

Authors:  Kazuyoshi Shigehara; Kouji Izumi; Kazufumi Nakashima; Shohei Kawaguchi; Takahiro Nohara; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Transl Androl Urol       Date:  2020-12

8.  Calcitonin gene-related peptide alters the firing rates of hypothalamic temperature sensitive and insensitive neurons.

Authors:  Daniel C Braasch; Erin M Deegan; Eleanor R Grimm; John D Griffin
Journal:  BMC Neurosci       Date:  2008-07-11       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.